HCA Healthcare, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by HCA Healthcare, Inc. on February 25, 2026, covering events occurring on February 20, 2026, and February 24, 2026. The filing addresses corporate governance changes and the adoption of a new executive compensation program.
Key Financial Metrics
The filing does not provide specific financial results, revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses on the structure of executive compensation rather than reporting period financial performance.
Material Changes and Corporate Actions
- Executive Compensation Program: On February 24, 2026, the Compensation Committee adopted the 2026 Executive Officer Performance Excellence Program (Executive Officer PEP). Awards are weighted 80% on EBITDA targets and 20% on quality metrics (Healthcare-Associated Infections and Sepsis, Complication and Mortality, and Care Experience). Payouts are cash-only and subject to a threshold where no quality portion is paid if actual EBITDA falls below 90% of the target.
- Target Award Percentages:
- Samuel N. Hazen (CEO): 175% of base salary.
- Michael A. Marks (CFO) and Jon M. Foster (COO): 125% of base salary.
- Michael R. McAlevey (Chief Legal and Administrative Officer) and Michael S. Cuffe, M.D. (Chief Clinical Officer): 100% of base salary.
- Board of Directors Change: Robert J. Dennis announced his retirement from the Board of Directors, effective at the annual meeting of stockholders on April 23, 2026.
Guidance, Risks, and Contingencies
The filing outlines clawback provisions, allowing the Company to recover or adjust awards if operating results are restated or if a participant's conduct materially disrupts the business. The Compensation Committee retains discretion to adjust targets for unusual events or changes in governmental definitions of quality metrics. No forward-looking financial guidance or specific risk factors regarding market conditions were disclosed in this report.
Investor Verification Checklist
- Review the full text of the 2026 Executive Officer Performance Excellence Program (Exhibit 10.1) for specific EBITDA and quality metric definitions.
- Confirm the impact of Robert J. Dennis's retirement on Board committee assignments and governance structure.
- Monitor upcoming earnings reports to assess if the 90% EBITDA threshold for quality metric payouts is at risk.
- Verify the specific base salary figures for named executive officers to calculate potential maximum cash payouts.